Early results show world-first adaptive trial in action for progressive MS
17 September 2026
A potential treatment for progressive multiple sclerosis (MS) will continue in a world-first multi-arm, multi-stage adaptive trial after showing encouraging early signs, with recruitment set to expand across Australia.
Alpha lipoic acid shows promise in Stage 1 of Octopus trial in progressive MS
17 September 2026
Results from Stage 1 of the Octopus trial find one of the trial treatments, alpha lipoic acid, shows promise in progressive MS and will continue into trial Stage 2.
Women and MS: one of the disease’s biggest mysteries
9 September 2026
Why does MS affect women more often than men? How does female biology impact MS activity? Discover what recent research is revealing about risk, hormones, immunity and EBV.
